Date Form Description PDF XBRL Pages
03/31/16 20-F Annual and transition report of foreign private issuers pursuant to Section 13 or 15(d)
Documents expand_more
PDF 192
03/27/15 20-F Annual and transition report of foreign private issuers pursuant to Section 13 or 15(d) PDF 321
03/31/14 20-F Annual and transition report of foreign private issuers pursuant to sections 13 or 15(d)
Documents expand_more
PDF 231

Upon receiving a request from any shareholder of Can-Fite BioPharma Ltd. who wishes to receive a hard copy of the Company’s complete audited financial statements, the Company will furnish such audited financial statements free of charge.  Such request may either be directed to Can-Fite BioPharma Ltd., 26 Ben Gurion Street, Ramat Gan 5257346 Israel, Attn: Chief Financial Officer or to info@canfite.com.